Here’s the thing. I have decades of experience with the markets and I have never seen so much economic uncertainty.
See, in the U.S. coming off coronavirus lockdowns varies not just by states but often by individual cities and counties. Something similar is occurring all around the world, making recovery forecasts difficult.
Meantime, you have some health experts and aggressive government officials suggesting lockdowns should continue until we find a Covid-19 vaccine.
Like I said, a lot of economic noise out there.
But fortunately, I have found a great tech leader that embodies Rule No. 2 – and I mean that quite literally. It’s a firm with a pole position in the 5G wireless race.
Despite the coronavirus panic – or perhaps because of it – the robotics industry recently saw deals worth $3 billion.
Here’s the thing. We’re just scratching the surface here.
That amount only covers high-profile deals by two major Silicon Valley firms. One was for venture capital funding and the other for a big merger.
But quietly and behind the scenes, robotics and automation firms garnered at least another $3.9 billion in funding.
And that’s just for February and March of this year.
So, it should come as no surprise that with the coronavirus serving as a fresh catalyst, robotics adoption is likely to grow significantly from here.
After all, one of the most significant effects of the coronavirus has been the fact that it has driven businesses to get human hands off of important work, whether that’s through digital connections or robotic automation.
A new report by MarketsandMarkets says that just the use of industrial bots will grow by roughly 10.4% year, meaning it will double by the end of this decade to more than $73 billion.
When we talked on Tuesday, I showed why you should wait until after a new IPO sells before investing.
In fact, after its initial drop, Veeva Systems Inc. (VEEV) went on to earn 863% in just a tad over five years.
Here’s the thing. During that same period the benchmark S&P 500 earned a respectable 70%. In other words, our play on cloud services for the life sciences sector beat the market’s benchmark by 1,132.9%.
That kind of return happens all the time in high tech, which I have proven time and again is the road to wealth.
With a high-octane stock like Veeva, $25,000 can turn into $240,750 in half a decade, with plenty of upside still ahead. You just need a handful of these tech-centric market crushers to become a millionaire.
Today, I’m following up to show you why Veeva is such a great long term play on the $1.2 trillion drug and biotech sector.